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ObjectiveTo date, 3 rare missense mutations in the SNCA (α-synuclein) gene and the
more frequent duplications or triplications of the wild-type gene are known to cause
a broad array of clinical and pathological symptoms in familial Parkinson disease
(PD). Here, we describe a French family with a parkinsonian–pyramidal syndrome
harboring a novel heterozygous SNCA mutation. Methods Whole exome sequencing
of DNA from 3 patients in a 3-generation pedigree was used to identify a new PD-
associated mutation in SNCA. Clinical and pathological features of the patients were
analyzed. The cytotoxic effects of the mutant and wild-type proteins were assessed
by analytical ultracentrifugation, thioflavin T binding, transmission electron
microscopy, cell viability assay, and caspase-3 activation. Results We identified a
novel SNCA G51D (c.152 G>A) mutation that cosegregated with the disease and was
absent from controls. G51D was associated with an unusual PD phenotype
characterized by early disease onset, moderate response to levodopa, rapid
progression leading to loss of autonomy and death within a few years, marked
pyramidal signs including bilateral extensor plantar reflexes, occasionally spasticity,
and frequently psychiatric symptoms. Pathological lesions predominated in the basal
ganglia and the pyramidal tracts and included fine, diffuse cytoplasmic inclusions
containing phospho-α-synuclein in superficial layers of the cerebral cortex, including
the entorhinal cortex. Functional studies showed that G51D α-synuclein
oligomerizes more slowly and its fibrils are more toxic than those of the wild-type
protein. Interpretation We have identified a novel SNCA G51D mutation that causes
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